Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Which Path Forward For Foundation Medicine?

Jun 17 2015

• By Mark Ratner

Related Content

With Genoptix, Novartis Continues Its Diagnostics Build-up

Feb 01 2011

Illumina Goes Consumer

Jun 01 2009

Illumina’s Unique Leverage In NIPT

Sep 10 2013

FDA Plan To Regulate LDTs Includes Long Phase-In, Unmet-Need Exceptions

Jul 31 2014

When Illumina Buys Roche: The Dawning Of The Era Of Diagnostics Dominance

Jul 28 2014

Related Companies

Foundation Medicine, Inc.

Roche Holding AG

Ventana Medical Systems, Inc.

Chugai Pharmaceutical Co., Ltd.

Genentech, Inc.

Novartis AG

Eisai Co., Ltd.

Eisai Co., Ltd.

Illumina, Inc.

Thermo Fisher Scientific

Additional Topics

Business Strategies Strategy Personalized Medicine Medical Device BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window